Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03608150 · ClinicalTrials.gov registry record · NA
Luminopia One Amblyopia Vision Improvement Study
A NA study, sponsored by Luminopia.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT03608150 is a NA study that has completed, run by Luminopia. The registered enrollment target is 117 participants.
The verdict
NCT03608150, a NA study, has completed, sponsored by Luminopia.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate the safety and efficacy of Luminopia One in amblyopia patients with amblyopia associated with anisometropia and/or with mild strabismus.
Interventions
- DEVICE Luminopia One
- DEVICE Refractive Correction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2019-01-16 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03608150
The ClinicalTrials.gov registry entry for NCT03608150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminopia, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Luminopia One is the first listed.
NCT03608150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03608150 about?
NCT03608150 is a clinical study titled "Luminopia One Amblyopia Vision Improvement Study". The objective of the study is to demonstrate the safety and efficacy of Luminopia One in amblyopia patients with amblyopia associated with anisometropia and/or with mild strabismus.
What is the current status of trial NCT03608150?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2019-01-16. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03608150?
The interventions under investigation include: Luminopia One (DEVICE), Refractive Correction (DEVICE).
Who is sponsoring clinical trial NCT03608150?
This trial is sponsored by Luminopia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.